- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.01. | Flurotech Ltd (2): Flurotech to resume at Jan. 14 open | 1 | Stockwatch | ||
| FLUROTECH Aktie jetzt für 0€ handeln | |||||
| 10.01. | Flurotech Ltd (2): Flurotech applies for trading resumption, appoints CFO | 1 | Stockwatch | ||
| 09.01. | FluroTech appoints Reem Chalhoub as CFO | 1 | Seeking Alpha | ||
| 09.01. | FluroTech Ltd.: FluroTech Ltd. Announces Application for Resumption of Trading, AGM Deficiency Update, and CFO Appointment | 539 | Newsfile | Toronto, Ontario--(Newsfile Corp. - January 9, 2026) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce that it has applied to the NEX board of the TSX Venture... ► Artikel lesen | |
| 13.06.25 | FluroTech Ltd. Announces Change in Directors | 496 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 13, 2025) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce that effective June 12, 2025, Eric Corbett has been appointed... ► Artikel lesen | |
| 13.05.25 | FluroTech Ltd. Announces Change in Management and Directors | 387 | Newsfile | Calgary, Alberta--(Newsfile Corp. - May 13, 2025) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") announces that effective December 16, 2024, Dr. Brendan Miles and Michael Rodyniuk have... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 41,350 | -3,62 % | BERENBERG stuft QIAGEN NV auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Qiagen von 46 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Inmitten der Übernahmespekulationen liefere der... ► Artikel lesen | |
| DISC MEDICINE | 65,56 | +17,18 % | Disc Medicine Inc: Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP | FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use... ► Artikel lesen | |
| POLARYX THERAPEUTICS | 3,940 | 0,00 % | Morning Market Movers: Polaryx Therapeutics, JIADE, ZIM Integrated Shipping Services, Masimo Corporation See Big Swings | WASHINGTON (dpa-AFX) - At 7:05 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 72,87 | 0,00 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights | Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to separate its early-stage precision cardiology... ► Artikel lesen | |
| KINIKSA PHARMACEUTICALS | 45,380 | +0,02 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Provides Corporate Update | - ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million --... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 69,64 | +2,74 % | Here is Why Apogee Therapeutics (APGE) Appears Attractive | ||
| IMMUNOVANT | 26,280 | 0,00 % | Immunovant Inc.: Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025 | IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the second half of calendar year 2026; topline data from... ► Artikel lesen | |
| TAYSHA GENE THERAPIES | 4,580 | +0,66 % | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome | First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to Reached written alignment with FDA on inclusion of =3 months of safety data from ASPIRE trial evaluating TSHA-102... ► Artikel lesen | |
| COGENT BIOSCIENCES | 37,630 | +3,01 % | Cogent Biosciences, Inc. - 10-K, Annual Report | ||
| ERASCA | 12,440 | 0,00 % | Erasca, Inc.: Erasca Announces Pricing of Upsized Public Offering of Common Stock | SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for... ► Artikel lesen | |
| STRUCTURE THERAPEUTICS | 71,33 | +1,80 % | Structure Therapeutics Inc.: Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity | SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| ARCELLX | 70,23 | +2,53 % | Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study | ||
| DYNE THERAPEUTICS | 15,270 | -1,74 % | Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry | ||
| RECURSION PHARMACEUTICALS | 3,465 | 0,00 % | Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards? | ||
| PRAXIS PRECISION MEDICINES | 327,42 | +3,21 % | Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) |
Das Unternehmen FLUROTECH LTD kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FLUROTECH LTD finden Sie auf Wallstreet Online.